Cite
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates.
MLA
Sanders, John W., et al. “Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates.” Vaccines, vol. 12, no. 5, May 2024, p. 451. EBSCOhost, https://doi.org/10.3390/vaccines12050451.
APA
Sanders, J. W., Ewing, D., Sundaram, A. K., Gamble, C. S., Blevins, M., Liang, Z., Sanders, L. A., Ornelles, D. A., Sun, P., Lenart, K., Feuerstein, H., Loré, K., Petrovsky, N., Williams, M., & Porter, K. R. (2024). Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates. Vaccines, 12(5), 451. https://doi.org/10.3390/vaccines12050451
Chicago
Sanders, John W., Daniel Ewing, Appavu K. Sundaram, Christopher Scott Gamble, Maria Blevins, Zhaodong Liang, Leigh Ann Sanders, et al. 2024. “Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates.” Vaccines 12 (5): 451. doi:10.3390/vaccines12050451.